Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

NCT00949442 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine (HOE901) [Lantus]
DRUG: Glimepiride
DRUG: human insulin [NPH]

Sponsor

Sanofi